[Occurrence of Helicobacter pylori strains resistant to metronidazole]

E Andrzejewska1, J Jenek, H Klincewicz

  • 1Zakład Mikrobiologii Lekarskiej i Klinika Gastroenterologii AM im. Karola Marcinkowskiego w Poznaniu.

Medycyna Doswiadczalna I Mikrobiologia
|January 1, 1994
PubMed

Insights

High rates of metronidazole resistance in Helicobacter pylori strains were observed in patients with gastritis. This highlights the critical need for ongoing monitoring of antibiotic susceptibility in H. pylori infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Helicobacter pylori (H. pylori) is a common cause of gastritis and peptic ulcers.
  • Metronidazole is a frequently used antibiotic for H. pylori eradication therapy.
  • Increasing antibiotic resistance poses a significant challenge to effective treatment.

Purpose of the Study:

  • To investigate the in vitro susceptibility of clinical Helicobacter pylori isolates to metronidazole.
  • To determine the prevalence of metronidazole resistance in H. pylori strains from patients with gastritis.

Main Methods:

  • Clinical strains of H. pylori were isolated from patients undergoing gastritis diagnosis.
  • Antibiotic susceptibility testing was performed using the disc diffusion method.
  • Isolates were analyzed for resistance patterns against metronidazole.

Main Results:

  • H. pylori was successfully isolated from 44 (67.7%) of the patients studied.
  • A high prevalence of metronidazole resistance was found, with 36 (81.8%) of the H. pylori strains exhibiting resistance.
  • Resistance rates were comparable between strains isolated from men (79.2%) and women (85%).

Conclusions:

  • The study reveals a significant level of metronidazole resistance in clinical H. pylori isolates.
  • Monitoring drug resistance patterns is crucial for guiding effective H. pylori eradication therapy.
  • These findings underscore the importance of antimicrobial stewardship in managing H. pylori infections.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...